MicroArray Facility: a laboratory information management system with extended support for Nylon based technologies
- Paul Honoré†1,
- Samuel Granjeaud†2,
- Rebecca Tagett1,
- Stéphane Deraco1, 5,
- Emmanuel Beaudoing2, 3,
- Jacques Rougemont2, 3,
- Stéphane Debono†1 and
- Pascal Hingamp†2, 4Email author
© Honoré et al; licensee BioMed Central Ltd. 2006
Received: 29 March 2006
Accepted: 20 September 2006
Published: 20 September 2006
High throughput gene expression profiling (GEP) is becoming a routine technique in life science laboratories. With experimental designs that repeatedly span thousands of genes and hundreds of samples, relying on a dedicated database infrastructure is no longer an option.
GEP technology is a fast moving target, with new approaches constantly broadening the field diversity. This technology heterogeneity, compounded by the informatics complexity of GEP databases, means that software developments have so far focused on mainstream techniques, leaving less typical yet established techniques such as Nylon microarrays at best partially supported.
MAF (MicroArray Facility) is the laboratory database system we have developed for managing the design, production and hybridization of spotted microarrays. Although it can support the widely used glass microarrays and oligo-chips, MAF was designed with the specific idiosyncrasies of Nylon based microarrays in mind. Notably single channel radioactive probes, microarray stripping and reuse, vector control hybridizations and spike-in controls are all natively supported by the software suite. MicroArray Facility is MIAME supportive and dynamically provides feedback on missing annotations to help users estimate effective MIAME compliance. Genomic data such as clone identifiers and gene symbols are also directly annotated by MAF software using standard public resources. The MAGE-ML data format is implemented for full data export. Journalized database operations (audit tracking), data anonymization, material traceability and user/project level confidentiality policies are also managed by MAF.
MicroArray Facility is a complete data management system for microarray producers and end-users. Particular care has been devoted to adequately model Nylon based microarrays. The MAF system, developed and implemented in both private and academic environments, has proved a robust solution for shared facilities and industry service providers alike.
Transcriptome surveying using microarrays has become an established and widespread technique. Although glass based microarrays and oligonucleotide chips are common in the gene expression profiling (GEP) landscape, Nylon supported microarrays coupled with radioactive detection, either home made [2–9] or from industrial suppliers [10–14], are an alternative still favored by some researchers, including the NIH's National Institute on Aging [16–19]. The resilience of this platform can be explained by the easy setup of this technical combination, its high sensitivity achieved without target amplification, and its cost effectiveness. Technological development for this platform is ongoing, as demonstrated by a two 'isotope' dual channel variant that uses real time emission integration.
Regular increase in microarray reporter densities together with falls in unitary costs have meant experiments routinely generate tens of millions of data pieces to store, search and analyze. For all but occasional microarray users, dedicated laboratory information management systems (LIMS) are now a requirement. Arguably one reason bench scientists are yielding to laboratory databases is increasing pressure from journal editors to have data appropriately submitted to international repositories as a prerequisite for publication.
Amongst the gene expression profiling LIMS that have been reported [24–34], glass dual channel Cy5/Cy3 and oligonucleotide chips are extremely well catered for. However, Nylon based microarrays are at best marginally supported by these software, with more substantial Nylon support only to be found in commercial products. Drawing on experience with a previous LIMS, the specific functionalities that we have found critical for comprehensive Nylon based microarrays modeling include the ability to record so called 'vector' hybridizations (quantitations of spotted reporter amounts), the stripping and recycling of microarrays and to model controls spiked into RNA samples [20, 38]. Finally, the pharmaceutical industry manufacturing and regulatory rigor required for the development of diagnostic applications are typically not of major concern in freely available LIMS.
Here we report the development of MAF (MicroArray Facility), a LIMS designed to accommodate the following desiderata:
- stringent quality control, traceability and audit tracking to meet industrial requirements
- multi-platform support (i.e. Nylon, glass, and oligo-based microarrays)
- rich data annotation for MIAME standard compatibility
- support for oncogenomic projects (i.e. clinical data)
- dynamic cDNA reporter annotation using public data banks (notably UNIGENE)
- MAGE-ML enabled
- import robotic equipment files in native formats to reduce error-prone reformatting
- multi-user privilege environment to promote data sharing and ensure confidentiality.
The scope of MAF (as defined in ) is a local LIMS serving a community of researchers, such as found around academic shared facilities or commercial array and service providers. The MAF user interface is entirely web browser contained, thus there is no technical contra-indication to using MAF as a means to publish datasets over the Internet. However one-stop shops for gene expression data have innumerable advantages for public data mining; thus we strongly recommend uploading public data to international archives such as ArrayExpress, CIBEX or GEO as a mechanism for publishing data.
MAF is a LIMS sensu stricto in that it records, tracks, structures, searches and reports all information required to establish gene expression profiles. High level downstream data analyses are carried out by exporting selected data to any of the myriad of dedicated analysis packages such as Cluster, BioConductor, MeV or ProfileSoftware.
MAF follows a client-server architecture implemented as a web-based application, allowing simultaneous multi-user access to a central database. Client browsers connect to an Apache server in a Unix/Linux environment. The application is entirely written in Perl; since the Perl packages rely on the abstract DBI module, switching between different Relational Database Management systems (RDBMS) is as simple as changing a single line in the MAF configuration file. MAF has been implemented, tested and validated for the Oracle 8i and the PostgreSQL RDBMS. With Oracle 8i, certain Oracle-specific features such as backup tools and transportable table spaces can also be used. Having deliberately avoided RDBMS specific SQL syntax, we believe that MAF is easily portable to other SQL database platforms that have a Perl DBD driver.
The relational database underlying MAF – composed of 2258 fields held in 215 tables – is called ELOGE. Its schema extends the conceptual ArrayExpress design which integrates microarray design and manufacturing, sample description, hybridization and data acquisition. Through a 5-year development cycle, ELOGE was considerably expanded to integrate fine grain modelling of wet lab routine procedures such as plate management, PCR quality control annotations, sequencing results, analytic validation, and GLP (Good Laboratory Practices) compliant protocols. The database scheme is designed to avoid computation-intensive queries and optimize user interface responsiveness.
MAF user data are collected through web form cascades (Fig. 2). Where appropriate (e.g. array layouts or image quantitations) data files are uploaded using background queue processing to avoid tying-up the interface. Many instrument and third party software data files are thus directly imported using a large set of data formatting drivers (Table 1). MAF web forms can be used to add, update or view data. However, browsing MAF data is best achieved through a collection of hyper linked data reports specific for each step of GEP processing (Table 2).
Equipment and third party software which are directly compatible with Microarray Facility.
MAF web form
Affymetrix 417 (ex GMS 417)
Microgrid II (Genomic Solutions)
Raytest TINA (agarose gels)
PCB + BMP
ArrayGauge 2.1 (Fuji)
BZScan 1.0 (INSERM)
GenePix 3.0 (Axon)
Imagene 4.0 (BioDiscovery)
ProfileSoftware Corporate/Cancer (Ipsogen)
ProfileSoftware Corporate (Ipsogen)
Any (PDF, Text, DOC etc.)
List of objects that can be stored and queried from the MicroArray Facility web interface.
Purified PCR run
Array analytic validation
Array batch analytic validation
Results and discussion
Clone library management
MAF clone management models the laboratory procedures for clone handling through wells, plates and plate sets. The LIMS precisely tracks clones from the resource plate to the array through replication, reorganisation, amplification and spotting steps.
Another example of MAF's routine quality controls is the update of sequence verified clone identities by monthly BLAST analysis and checking of clone to UNIGENE cluster associations.
MAF manages every step of array production from abstract print type and array type definitions to batch production runs of physical arrays. A custom produced array design can be created by directly uploading layout definition files from spotting robots (e.g. Microgrid II or GMS), hence avoiding error-prone manual entry of the array design. Bypassing printing steps, microarrays or even oligo-chips from third party providers can also be loaded into MAF, albeit with less detailed annotation at the array design level.
In the case of Nylon based arrays, MAF manages the "vector probe hybridisation" post-production quality control. This step measures the quantity of reporter material bound at each spot through batch hybridisation of filters with a labelled oligonucleotide (the sequence of which is common to every spotted clone), followed by filter stripping.
Every array produced can be tracked down to the projects and hybridizations in which it has been used.
Expression profiling data user submission
MAF data is partitioned into projects containing one or more experiments. An experiment ties together any number of hybridizations, usually all undertaken as part of the same experimental design. Experimental data submission follows the flow leading from biological samples to RNA extraction, labelling, hybridization, scanning, image feature extraction, and finally normalisation of measurements.
Feature extraction (image quantitation) results can be imported in a number of common software formats such as BZscan, ArrayGauge, Genepix, Imagene, and ProfileSoftware. Where a format is not supported MAF provides a simple generic tab delimited format that can easily be produced with a spreadsheet program.
External controls added to labelled samples, such as RNA spike-ins which are commonly used with Nylon filters, are also quantitatively represented by MAF for a more accurate assessment of quality control and for spike based data set normalization.
MAF representation of biological samples links individuals, samples, RNA extracts and labelled extracts, each with a many-to-many cardinality. Rich quantitative and qualitative annotation of both individuals and samples is supported (e.g. code, age, mass, sex, tumor grade etc.), using either standard nomenclatures (such as oncology terms) or user defined parameters. This controlled vocabulary annotation of samples is of paramount importance for effective downstream correlation of expression profiles with experimental, biological and clinical factors.
Data annotation and MIAME compliance
Results from high throughput gene expression profiling experiments differ from single gene measurements in that the effects of many more experimental parameters are likely to be observed. The proper correlation of expression signatures with biological parameters therefore requires careful recording of all known experimental variables.
This long recognized specificity of transcriptome analysis has led the Microarray Gene Expression Data Society (MGED) to draw up MIAME, a set of minimal annotation guidelines for microarray based experiments. All three international gene expression archives support MIAME standard data annotation, and an increasing number of scientific editors are requiring MIAME grade data for publication in their journals.
Thus MIAME compatibility has been a design ambition for the development of MicroArray Facility since its inception. This has directly impacted the underlying MAF data scheme as can still be seen in the [individual > sample > extract > labeled extract] part of the model. Defined name spaces for MIAME annotation are reserved in all relevant parts of the database relations. The annotation is either collected through web forms from the user (e.g. hybridization protocol), or generated automatically by MAF using imported public data (e.g. gene symbols from ENTREZ GENE or SWISSPROT).
Pivotal in MIAME is the requirement to attach laboratory protocols for all experimental steps. MAF has 15 protocol categories which are user supplied documents (e.g. text or PDF files) supplemented with optional or obligatory variable parameters, e.g. exposure time for "Image Acquisition" protocols.
Since software can only be 'MIAME supportive', i.e. potentially able to store the required annotation, MAF provides a MIAME check-list to help researchers make sure their data is actually MIAME compliant. The check list, accessible at any time, reports any missing annotation, in particular required protocols currently undefined in the project.
Data export and interoperability
Data collected through the forms and their associated annotations can be viewed at any time through specific web reports launched from the permanent search box in the form header. All reports are dynamically hyper linked facilitating navigation across object categories. Displayed data can also be directly downloaded as tabulated text files. A more substantial reporting tool is also provided for more transversal data searches, such as finding all samples verifying specific criteria, for instance tumor grade or patient age. Search results are exported as classical flat file datasets including comprehensive sample and reporter annotations as well as the expression measurements. This text file format is compatible with most downstream analysis tools such as BioConductor, Cluster or ProfileSoftware [46–48].
MAF also currently provides an experimental MAGE-ML complete experiment export functionality comprising all MAGE packages (ArrayDesign, DesignElement, Experiment, BioAssay, BioMaterial, BioAssayData) suitable for exporting to data archives or to MAGE-ML enabled data analysis tools. The MAF produced MAGE-ML has been validated and a test experiment was successfully pipelined into ArrayExpress.
Regulatory agencies are currently working to define a proper regulatory environment for GEP use in drug development and market approval processes. A guidance on Pharmacogenomic Data Submissions was issued by the FDA in March 2005. This document defines the rules to be followed in order to ensure that GEP data submitted for drug approval will have the quality level required by the FDA.
Compliance with FDA 21 CFR part 11 regulations is audited at least once a year. The production version of MAF is currently 80% compliant with 21 CFR part 11. Ongoing developments aim to reach full MAF compliance with Good Laboratory Practices (GLPs). Guidelines for archiving records and standard operating procedures (SOPs) are distributed with the commercial version of the MAF (Discovery Software, see licensing).
Comparison of microarray LIMS with regard to licencing, specific technology support, regulatory compliance, MIAME compliance and Mage-ML export.
Specific Support for
21 CFR part 11
National Human Genome Research Institute (NHGRI)
GeneX Va/GEOSS 2.5.2
University of Virginia
Medical Research Council (MRC) Harwell
The Institute for Genomic Research (TIGR)
University of Florida
Graz University of Technology
University of Manchester
Ipsogen/Institut National de la Santé et de la Recherche Médicale (INSERM)
Politecnico di Milano
Imperial College London
German Cancer Research Institute
SMD/Longhorn Array Database 1.5
GeneSpring GX Workgroup
Importantly, the MAF system has been tried and tested in both academic shared facilities and industrial environments managing cDNA and Affymetrix gene expression projects. Running in production for five years, MAF has established itself as a central information hub in the laboratory. Investment in data entry is rewarded by providing researchers with fast answers to common queries (e.g. "what is the expression profile of this new marker in our previously tested tumors?") and by helping extract more biological meaning from collected data.
Availability and requirements
• Project name: MicroArray Facility (MAF)
• Project home page:http://tagc.univ-mrs.fr/bioinformatics/maf/
• Operating system(s): Platform independent
• Programming language: Perl, SQL
• Other requirements: Web Server (e.g. Apache), RDBMS (Oracle or PostgreSQL), MAGEstk
• Licensing: Royalty free, non-exclusive, non-transferable INSERM license for academics (excluding SOPs)
• Any restrictions to use by non-academics: Discovery Software license from IPSOGEN SAS
We wish to thank Karine Achache, Cédric Bouttes, Régis Brachet-Cota, Vincent Casteras, Frédéric Marciano, Nicolas Mouriaux, David Ruau, Marc Simoni, Virginie Stéphan and David Zinn for their contributions to MAF development. We also thank Helen Parkinson for her help in testing MAGE-ML upload into ArrayExpress. This development was supported by EU grant QLRT-2001-00015 (Temblor/DESPRAD) and the Ipsogen Bioinformatics Department.
- Chaudhuri JD: Genes arrayed out for you: the amazing world of microarrays. Med Sci Monit. 2005, 11: RA52-62.PubMed
- Auger CJ, Jessen HM, Auger AP: Microarray profiling of gene expression patterns in adult male rat brain following acute progesterone treatment. Brain Res. 2006, 1067: 58-66. 10.1016/j.brainres.2005.10.033.PubMedView Article
- Cardoso RS, Junta CM, Macedo C, Magalhaes DAR, Silveira ELV, Paula MO, Marques MMC, Mello SS, Zarate-Blades CR, Nguyen C, Houlgatte R, Donadi EA, Sakamoto-Hojo ET, Passos GAS: Hybridization signatures of gamma-irradiated murine fetal thymus organ culture (FTOC) reveal modulation of genes associated with T-cell receptor V(D)J recombination and DNA repair. Mol Immunol. 2006, 43: 464-472. 10.1016/j.molimm.2005.03.010.PubMedView Article
- Yamamoto H, Imai K, Takamatsu Y, Kamegaya E, Kishida M, Hagino Y, Hara Y, Shimada K, Yamamoto T, Sora I, Koga H, Ikeda K: Methamphetamine modulation of gene expression in the brain: analysis using customized cDNA microarray system with the mouse homologues of KIAA genes. Brain Res Mol Brain Res. 2005, 137: 40-46. 10.1016/j.molbrainres.2005.02.028.PubMedView Article
- Thieblemont C, Nasser V, Felman P, Leroy K, Gazzo S, Callet-Bauchu E, Loriod B, Granjeaud S, Gaulard P, Haioun C, Traverse-Glehen A, Baseggio L, Bertucci F, Birnbaum D, Magrangeas F, Minvielle S, Avet-Loiseau H, Salles G, Coiffier B, Berger F, Houlgatte R: Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis. Blood. 2004, 103: 2727-2737. 10.1182/blood-2003-06-2160.PubMedView Article
- Charafe-Jauffret E, Bertucci F, Ramuz O, Devilard E, Gaulard P, Brousset P, Houlgatte R, Hassoun J, Birnbaum D, Xerri L: Characterization of Hodgkin's lymphoma-like undifferentiated carcinoma of the nasopharyngeal type as a particular UCNT subtype mimicking Hodgkin's lymphoma. Int J Oncol. 2003, 23: 97-103.PubMed
- Devilard E, Bertucci F, Trempat P, Bouabdallah R, Loriod B, Giaconia A, Brousset P, Granjeaud S, Nguyen C, Birnbaum D, Birg F, Houlgatte R, Xerri L: Gene expression profiling defines molecular subtypes of classical Hodgkin's disease. Oncogene. 2002, 21: 3095-3102. 10.1038/sj.onc.1205418.PubMedView Article
- Bertucci F, Salas S, Eysteries S, Nasser V, Finetti P, Ginestier C, Charafe-Jauffret E, Loriod B, Bachelart L, Montfort J, Victorero G, Viret F, Ollendorff V, Fert V, Giovaninni M, Delpero J, Nguyen C, Viens P, Monges G, Birnbaum D, Houlgatte R: Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene. 2004, 23: 1377-1391. 10.1038/sj.onc.1207262.PubMedView Article
- Magrangeas F, Nasser V, Avet-Loiseau H, Loriod B, Decaux O, Granjeaud S, Bertucci F, Birnbaum D, Nguyen C, Harousseau J, Bataille R, Houlgatte R, Minvielle S: Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease. Blood. 2003, 101: 4998-5006. 10.1182/blood-2002-11-3385.PubMedView Article
- Vey N, Mozziconacci M, Groulet-Martinec A, Debono S, Finetti P, Carbuccia N, Beillard E, Devilard E, Arnoulet C, Coso D, Sainty D, Xerri L, Stoppa A, Lafage-Pochitaloff M, Nguyen C, Houlgatte R, Blaise D, Maraninchi D, Birg F, Birnbaum D, Bertucci F: Identification of new classes among acute myelogenous leukaemias with normal karyotype using gene expression profiling. Oncogene. 2004, 23: 9381-9391. 10.1038/sj.onc.1207910.PubMedView Article
- Maroc N, Morel A, Beillard E, De La Chapelle AL, Fund X, Mozziconacci M, Dupont M, Cayuela J, Gabert J, Koki A, Fert V, Hermitte F: A diagnostic biochip for the comprehensive analysis of MLL translocations in acute leukemia. Leukemia. 2004, 18: 1522-1530. 10.1038/sj.leu.2403439.PubMedView Article
- Biberthaler P, Neth P, Bach B, Mayer V, Mussack T, Mutschler W, Jochum M: Initial RNA expression in human monocytes after multiple injury: a screening pilot study on potentially trauma-sensitive factors by using the microarray-technique. Eur J Med Res. 2003, 8: 473-484.PubMed
- Bertucci F, Borie N, Ginestier C, Groulet A, Charafe-Jauffret E, Adelaide J, Geneix J, Bachelart L, Finetti P, Koki A, Hermitte F, Hassoun J, Debono S, Viens P, Fert V, Jacquemier J, Birnbaum D: Identification and validation of an ERBB2 gene expression signature in breast cancers. Oncogene. 2004, 23: 2564-2575. 10.1038/sj.onc.1207361.PubMedView Article
- Seidel SD, Sparrow BR, Kan HL, Stott WT, Schisler MR, Linscombe VA, Gollapudi BB: Profiles of gene expression changes in L5178Y mouse lymphoma cells treated with methyl methanesulfonate and sodium chloride. Mutagenesis. 2004, 19: 195-201. 10.1093/mutage/geh027.PubMedView Article
- Simpson P, Jones C, Mackay A, Lakhani SR: Gene expression analysis using filter cDNA microarrays. Methods Mol Med. 2006, 120: 415-424.PubMed
- 10 Reasons For Using Nylon Based Microarrays. [http://www.daf.jhmi.edu/microarray/faq.htm]
- Tanaka TS, Ko MSH: A global view of gene expression in the preimplantation mouse embryo: morula versus blastocyst. Eur J Obstet Gynecol Reprod Biol. 2004, 115 (Suppl 1): S85-91. 10.1016/j.ejogrb.2004.01.026.PubMedView Article
- Herrera L, Ottolenghi C, Garcia-Ortiz JE, Pellegrini M, Manini F, Ko MSH, Nagaraja R, Forabosco A, Schlessinger D: Mouse ovary developmental RNA and protein markers from gene expression profiling. Dev Biol. 2005, 279: 271-290. 10.1016/j.ydbio.2004.11.029.PubMedView Article
- Wu Y, Zhang X, Bardag-Gorce F, Robel RCV, Aguilo J, Chen L, Zeng Y, Hwang K, French SW, Lu SC, Wan YY: Retinoid X receptor alpha regulates glutathione homeostasis and xenobiotic detoxification processes in mouse liver. Mol Pharmacol. 2004, 65: 550-557. 10.1124/mol.65.3.550.PubMedView Article
- Bertucci F, Bernard K, Loriod B, Chang YC, Granjeaud S, Birnbaum D, Nguyen C, Peck K, Jordan BR: Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples. Hum Mol Genet. 1999, 8: 1715-1722. 10.1093/hmg/8.9.1715.PubMedView Article
- Salin H, Vujasinovic T, Mazurie A, Maitrejean S, Menini C, Mallet J, Dumas S: A novel sensitive microarray approach for differential screening using probes labelled with two different radioelements. Nucleic Acids Res. 2002, 30: e17-10.1093/nar/30.4.e17.PubMedPubMed CentralView Article
- Barrett T, Suzek TO, Troup DB, Wilhite SE, Ngau W, Ledoux P, Rudnev D, Lash AE, Fujibuchi W, Edgar R: NCBI GEO: mining millions of expression profiles – database and tools. Nucleic Acids Res. 2005, 33: D562-6. 10.1093/nar/gki022.PubMedPubMed CentralView Article
- Ball CA, Brazma A, Causton H, Chervitz S, Edgar R, Hingamp P, Matese JC, Parkinson H, Quackenbush J, Ringwald M, Sansone S, Sherlock G, Spellman P, Stoeckert C, Tateno Y, Taylor R, White J, Winegarden N: Submission of microarray data to public repositories. PLoS Biol. 2004, 2: E317-10.1371/journal.pbio.0020317.PubMedPubMed CentralView Article
- Lee JK, Laudeman T, Kanter J, James T, Siadaty MS, Knaus WA, Prorok A, Bao Y, Freeman B, Puiu D, Wen LM, Buck GA, Schlauch K, Weller J, Fox JW: GeneX Va: VBC open source microarray database and analysis software. Biotechniques. 2004, 36: 634-8. 640, 642PubMed
- Saal LH, Troein C, Vallon-Christersson J, Gruvberger S, Borg A, Peterson C: BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data. Genome Biol. 2002, 3: SOFTWARE0003-10.1186/gb-2002-3-8-software0003.PubMedPubMed CentralView Article
- Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, Quackenbush J: TM4: a free, open-source system for microarray data management and analysis. Biotechniques. 2003, 34: 374-378.PubMed
- Killion PJ, Sherlock G, Iyer VR: The Longhorn Array Database (LAD): an open-source, MIAME compliant implementation of the Stanford Microarray Database (SMD). BMC Bioinformatics. 2003, 4: 32-10.1186/1471-2105-4-32.PubMedPubMed CentralView Article
- Kokocinski F, Wrobel G, Hahn M, Lichter P: QuickLIMS: facilitating the data management for DNA-microarray fabrication. Bioinformatics. 2003, 19: 283-284. 10.1093/bioinformatics/19.2.283.PubMedView Article
- McIndoe RA, Lanzen A, Hurtz K: MADGE: scalable distributed data management software for cDNA microarrays. Bioinformatics. 2003, 19: 87-89. 10.1093/bioinformatics/19.1.87.PubMedView Article
- Burgarella S, Cattaneo D, Pinciroli F, Masseroli M: MicroGen: a MIAME compliant web system for microarray experiment information and workflow management. BMC Bioinformatics. 2005, 6 (Suppl 4): S6-10.1186/1471-2105-6-S4-S6.PubMedPubMed CentralView Article
- Hancock D, Wilson M, Velarde G, Morrison N, Hayes A, Hulme H, Wood AJ, Nashar K, Kell DB, Brass A: maxdLoad2 and maxdBrowse: standards-compliant tools for microarray experimental annotation, data management and dissemination. BMC Bioinformatics. 2005, 6: 264-10.1186/1471-2105-6-264.PubMedPubMed CentralView Article
- Maurer M, Molidor R, Sturn A, Hartler J, Hackl H, Stocker G, Prokesch A, Scheideler M, Trajanoski Z: MARS: microarray analysis, retrieval, and storage system. BMC Bioinformatics. 2005, 6: 101-10.1186/1471-2105-6-101.PubMedPubMed CentralView Article
- Navarange M, Game L, Fowler D, Wadekar V, Banks H, Cooley N, Rahman F, Hinshelwood J, Broderick P, Causton HC: MiMiR: a comprehensive solution for storage, annotation and exchange of microarray data. BMC Bioinformatics. 2005, 6: 268-10.1186/1471-2105-6-268.PubMedPubMed CentralView Article
- Webb SC, Attwood A, Brooks T, Freeman T, Gardner P, Pritchard C, Williams D, Underhill P, Strivens MA, Greenfield A, Pilicheva E: LIMaS: the JAVA-based application and database for microarray experiment tracking. Mamm Genome. 2004, 15: 740-747. 10.1007/s00335-004-2357-5.PubMedView Article
- Anderle P, Duval M, Draghici S, Kuklin A, Littlejohn TG, Medrano JF, Vilanova D, Roberts MA: Gene expression databases and data mining. Biotechniques. 2003, 36-44. Suppl
- Imbert MC, Nguyen VK, Granjeaud S, Nguyen C, Jordan BR: 'LABNOTE', a laboratory notebook system designed for academic genomics groups. Nucleic Acids Res. 1999, 27: 601-607. 10.1093/nar/27.2.601.PubMedPubMed CentralView Article
- Donovan DM, Becker KG: Double round hybridization of membrane based cDNA arrays: improved background reduction and data replication. J Neurosci Methods. 2002, 118: 59-62. 10.1016/S0165-0270(02)00141-3.PubMedView Article
- Badiee A, Eiken HG, Steen VM, Lovlie R: Evaluation of five different cDNA labeling methods for microarrays using spike controls. BMC Biotechnol. 2003, 3: 23-10.1186/1472-6750-3-23.PubMedPubMed CentralView Article
- Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FC, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M: Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet. 2001, 29: 365-371. 10.1038/ng1201-365.PubMedView Article
- Wheeler DL, Barrett T, Benson DA, Bryant SH, Canese K, Chetvernin V, Church DM, DiCuccio M, Edgar R, Federhen S, Geer LY, Helmberg W, Kapustin Y, Kenton DL, Khovayko O, Lipman DJ, Madden TL, Maglott DR, Ostell J, Pruitt KD, Schuler GD, Schriml LM, Sequeira E, Sherry ST, Sirotkin K, Souvorov A, Starchenko G, Suzek TO, Tatusov R, Tatusova TA, Wagner L, Yaschenko E: Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2006, 34: D173-80. 10.1093/nar/gkj158.PubMedPubMed CentralView Article
- Spellman PT, Miller M, Stewart J, Troup C, Sarkans U, Chervitz S, Bernhart D, Sherlock G, Ball C, Lepage M, Swiatek M, Marks WL, Goncalves J, Markel S, Iordan D, Shojatalab M, Pizarro A, White J, Hubley R, Deutsch E, Senger M, Aronow BJ, Robinson A, Bassett D, Stoeckert CJJ, Brazma A: Design and implementation of microarray gene expression markup language (MAGE-ML). Genome Biol. 2002, 3: RESEARCH0046-10.1186/gb-2002-3-9-research0046.PubMedPubMed CentralView Article
- Gardiner-Garden M, Littlejohn TG: A comparison of microarray databases. Brief Bioinform. 2001, 2: 143-158. 10.1093/bib/2.2.143.PubMedView Article
- Brazma A, Robinson A, Cameron G, Ashburner M: One-stop shop for microarray data. Nature. 2000, 403: 699-700. 10.1038/35001676.PubMedView Article
- Parkinson H, Sarkans U, Shojatalab M, Abeygunawardena N, Contrino S, Coulson R, Farne A, Lara GG, Holloway E, Kapushesky M, Lilja P, Mukherjee G, Oezcimen A, Rayner T, Rocca-Serra P, Sharma A, Sansone S, Brazma A: ArrayExpress – a public repository for microarray gene expression data at the EBI. Nucleic Acids Res. 2005, 33: D553-5. 10.1093/nar/gki056.PubMedPubMed CentralView Article
- Ikeo K, Ishi-i J, Tamura T, Gojobori T, Tateno Y: CIBEX: center for information biology gene expression database. C R Biol. 2003, 326: 1079-1082.PubMedView Article
- Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998, 95: 14863-14868. 10.1073/pnas.95.25.14863.PubMedPubMed CentralView Article
- Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JYH, Zhang J: Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5: R80-10.1186/gb-2004-5-10-r80.PubMedPubMed CentralView Article
- Ipsogen Profilesoftware™. [http://www.ipsogen.com/services/index_data_analysis.html]
- Lopez F, Rougemont J, Loriod B, Bourgeois A, Loi L, Bertucci F, Hingamp P, Houlgatte R, Granjeaud S: Feature extraction and signal processing for nylon DNA microarrays. BMC Genomics. 2004, 5: 38-10.1186/1471-2164-5-38.PubMedPubMed CentralView Article
- Fujifilm Arraygauge™ Software. [http://home.fujifilm.com/products/science/si_software/arraygauge.html]
- Molecular Devices Genepix™ Software. [http://www.moleculardevices.com/pages/software/gn_genepix_pro.html]
- Biodiscovery Imagene™ Software. [http://www.biodiscovery.com/index/imagene]
- Microarray Gene Expression Data Society. [http://www.mged.org/]
- U. S. Food And Drug Administration Guidance For Industry Pharmacogenomic Data Submissions. [http://www.fda.gov/cber/gdlns/pharmdtasub.htm]
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.